| Authors: |
Kroenke MA; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Barger TE; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States., Hu J; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States., Miller MJ; Translational Safety & Bioanalytical Sciences, Amgen, Thousand Oaks, CA, United States., Kalenian K; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., He L; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., Hsu H; Inflammation Research, Amgen, Thousand Oaks, CA, United States., Bartley Y; Global Safety, Amgen, Thousand Oaks, CA, United States., Chow VF; Clinical Pharmacology, Modeling and Simulation, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Teixeira Dos Santos MC; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Sullivan BA; Clinical Biomarkers and Diagnostics, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Cheng LE; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Parnes JR; Early Development, Translational Medicine, Amgen, Thousand Oaks, CA, United States., Padaki R; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., Kuhns S; Process Development, Attribute Sciences, Amgen, Thousand Oaks, CA, United States., Mytych DT; Clinical Immunology, Translational Medicine, Amgen, Thousand Oaks, CA, United States. |